Parathyroid hormone-related protein-(1-36) is biologically active when administered subcutaneously to humans

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 3, 1997, Pages 900-906

  Henry, Jean G ^b   Mitnick, Maryann ^b   Dann, Pamela R ^b   Stewart, Andrew F ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CYCLIC AMP; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHORUS; SYNTHETIC PEPTIDE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; NORMAL HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CALCIUM; CYCLIC AMP; FEMALE; HALF-LIFE; HOMEOSTASIS; HUMANS; INJECTIONS, SUBCUTANEOUS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MINERALS; OSMOLAR CONCENTRATION; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; PHOSPHORUS; PROTEINS; VITAMIN D;

EID: 0031024785     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.3.900     Document Type: Article

References (26)

1. Broadus AE, Stewart AF. 1994 Parathyroid hormone-related protein: structure, processing and physiological actions. In: Bilezikian JP, Levine MA, Marcus R, eds. The parathyroids, basic and clinical concepts. New York: Raven Press; 259-294.
2. Orloff JJ, Reddy DR, dePapp AE, Yang KH, Soifer NE, Stewart AF. 1994 Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev. 15:40-60.
3. Everhart-Caye M, Inzucchi SE, Guinness-Henry J, Mitnick MA, Stewart AF. 1996 Parathyroid hormone-related protein-(1-36) is equipotent with parathyroid hormone-(1-34) in humans. J Clin Endocrinol Metab. 81:199-208.
4. Rabbani SA, Haq M, Goltzman D. 1993 Biosynthesis and processing of endogenous parathyroid hormone related peptide (PTHrP) by rat Leydig cell tumor H-500. Biochemistry. 32:4931-4937.
5. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE. 1980 Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and non-humoral groups. N Engl J Med. 303:1377-1383.
6. Stewart AF, Insogna KL, Broadus AE. 1995 Malignancy-associated hypercalcemia. In: DeGroot L, ed. Endocrinology, 3rd ed. Philadelphia: Saunders; 1061-1074.
7. Nakayama K, Fukumoto S, Takeda S, et al. 1996 Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia. J Clin Endocrinol Metab. 82:607-611.
8. Stewart AF, Vignery A, Silvergate A, et al. 1982 Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab. 55:219-227.
9. Yamata H, Nagai Y, Inoue D, et al. 1995 In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoraly hypercalcemia of cancer. J Bone Miner Res. 10:36-44.
10. Powell D, Singer FR, Murray TM, Minkin C, Potts Jr JT. 1973 Non-parathyroid humoral hyercalcemia in patients with neoplastic diseases. N Engl J Med. 289:176-181.
11. Ralston SH, Fogelman I, Gardner MD, Dryburgh FJ, Cowan RA, Boyle IT. 1984 Hypercalcaemia of malignancy: evidence for a non-parathyroid humoral agent with an effect on renal tubular handling of calcium. Clin Sci. 66:187-191.
12. Bonjour J-P, Philippe J, Guelpa G, et al. 1988 Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate. Bone. 9:123-130.
13. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev. 14:690-709.
14. Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM. 1993 An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J Clin Invest. 91:1138-1148.
15. Reeve J. 1996 PTH: a future role in the management of osteoporosis? J Bone Miner Res. 11:440-445.
16. Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MK, Schiff I, Neer RM. 1994 Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med. 331:1618-1623.
17. Hock JM, Fonseca J, Gunness-Hey M, Kemp BE, Martin TJ. 1989 Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats. Endocrinology. 125:2022-2027.
18. Weir EC, Terwilliger G, Sartori L, Insogna KL. 1992 Synthetic parathyroid hormone-like protein (1-74) is anabolic for bone in vivo. Calcif Tissue Int. 51:30-34.
19. 2D not requiring high performance liquid chromatography. J Clin Endocrinol Metab. 58:91-98.
20. Broadus AE. 1979 Nephrogenous cyclic AMP as a parathyroid function test. Nephron. 23:136-141.
21. Plawner LL, Philbrick WM, Burtis WJ, Broadus AE, Stewart AF. 1995 Secretion of parathyroid hormone-related protein: cell-specific secretion via the regulated vs. the constitutive secretory pathway. J Biol Chem. 270: 14078-14084.
22. Papapoulos SE, Manning RM, Hendy GN, Lewin IG, O'Riordan JLH. 1990 Studies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay. Clin Endocrinol (Oxf). 13:57-67.
23. Kent GN, Loveridge N, Reeve J, Zanelli JM. 1985 Pharmacokinetics of synthetic human parathyroid hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay. Clin Sci. 68:171-177.
24. Fraher LJ, Hodsman AB, Jonas K, et al. 1992 A comparison of the in vivo biological responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man. J Clin Endocrinol Metab. 75:417-423.
25. Lindsay R, Nieves J, Henneman E, Shen V, Cosman F. 1993 Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients. J Clin Endocrinol Metab. 77:1535-1539.
26. Fraher LJ, Klein K, Marier R, Freeman D, et al. 1995 Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans. J Clin Endocrinol Metab. 80:60-64.